- Home
- Personal stories
Personal stories
Conduit interview with Kris Sterkens
“We’re supporting the power of local ideas to create real, sustainable change.”
What you need to know about Johnson & Johnson’s 2021 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
2 pandemics, 1 goal: Meet 4 innovators with high-tech ideas for fighting tuberculosis in the time of COVID-19
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis.
Kenya launches new community health strategy
Co-created by the Johnson & Johnson Center for Health Worker Innovation with the Ministry of Health and other stakeholders, the effort aims to integrate community health workers formally into the health system.
4 things scientists now know about autoimmune diseases in kids
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production
Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
Meet three innovative nurse practitioners who are using a dental clinic to make primary care accessible
Whitney Nash, Michelle Baxter and Beverly Williams Coleman—alums of the Duke-Johnson & Johnson Nurse Leadership Program—discuss how they set up a primary care clinic in the University of Louisville School of Dentistry.
4 things we now know about the rare disease AL amyloidosis
Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.
A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine
The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.
“COVID-19 inspired me to improve patient care": How two nurses devised new ways to help kids and fellow nurses during the pandemic
From a virtual reality game that helps children with remote physical therapy to a clever way to upgrade personal protective equipment for healthcare workers, the winning ideas from the latest Johnson & Johnson Nurses Innovate QuickFire Challenge came out of medical conundrums posed by the pandemic. Meet the women behind them.